Heron Therapeutics, Inc. (HRTX)
NASDAQ: HRTX · Real-Time Price · USD
0.3752
+0.0132 (3.65%)
Oct 15, 2026, 4:00 PM EDT - Market closed
Heron Therapeutics Market Cap
Heron Therapeutics has a market cap or net worth of $70.83 million as of October 15, 2026. It is the 27,925th most valuable company in the world and the 4,410th biggest in the United States. Its market cap has decreased by 64.99% in one year.
Market Cap
70.83M
Enterprise Value
176.52M
1-Year Change
-64.99%
Global Rank
Country Rank
#4,410 United States
Category
ChartMarket Cap Chart
Since December 1, 1998, Heron Therapeutics's market cap has decreased from $127.40M to $70.83M, a decrease of -44.40%. That is a compound annual growth rate of -2.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 70.83M | -70.29% |
| Dec 31, 2025 | 238.40M | 2.45% |
| Dec 31, 2024 | 232.70M | -8.78% |
| Dec 29, 2023 | 255.10M | -14.17% |
| Dec 30, 2022 | 297.20M | -68.07% |
| Dec 31, 2021 | 930.70M | -51.60% |
| Dec 31, 2020 | 1.92B | -9.13% |
| Dec 31, 2019 | 2.12B | 4.57% |
| Dec 31, 2018 | 2.02B | 105.15% |
| Dec 29, 2017 | 986.50M | 92.15% |
| Dec 30, 2016 | 513.40M | -46.54% |
| Dec 31, 2015 | 960.40M | 227.11% |
| Dec 31, 2014 | 293.60M | 110.32% |
| Dec 31, 2013 | 139.60M | -15.24% |
| Dec 31, 2012 | 164.70M | 258.04% |
| Dec 30, 2011 | 46.00M | 154.14% |
| Dec 31, 2010 | 18.10M | -63.51% |
| Dec 31, 2009 | 49.60M | 281.54% |
| Dec 31, 2008 | 13.00M | -73.25% |
| Dec 31, 2007 | 48.60M | 39.66% |
| Dec 29, 2006 | 34.80M | -10.08% |
| Dec 30, 2005 | 38.70M | -6.30% |
| Dec 31, 2004 | 41.30M | -18.22% |
| Dec 31, 2003 | 50.50M | 146.34% |
| Dec 31, 2002 | 20.50M | -63.91% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nutriband | 79.98M |
| Telomir Pharmaceuticals | 79.51M |
| Cardiff Oncology | 78.57M |
| ProMIS Neurosciences | 77.57M |
| Pelthos Therapeutics | 77.43M |
| Acrivon Therapeutics | 75.64M |
| OKYO Pharma | 75.44M |
| MediciNova | 74.32M |